FITB
36
3
FIS
43
5
CPB
24
2
BIIB
36
8
EXR
42
5
HBAN
47
7
TXT
46
4
NWS
69
5
AEE
51
3
CLX
65
2
GME
61
2
TMO
52
8
WFC
58
8
ADP
57
2
LUV
45
3
ACN
54
2
APA
30
5
NWL
48
4
HRB
40
3
THC
52
9
FITB
36
3
FIS
43
5
CPB
24
2
BIIB
36
8
EXR
42
5
HBAN
47
7
TXT
46
4
NWS
69
5
AEE
51
3
CLX
65
2
GME
61
2
TMO
52
8
WFC
58
8
ADP
57
2
LUV
45
3
ACN
54
2
APA
30
5
NWL
48
4
HRB
40
3
THC
52
9
Financhill
Back

Niu Technologies 10K Form

Sell
29

NIU
Niu Technologies

Last Price:
$1.80
Seasonality Move:
-6.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NIU News And Ratings

See the #1 stock for the next 7 days that we like better than NIU

NIU Financial Statistics

Sales & Book Value

Annual Sales: $374.9M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.82
Price / Book: 0.97

Profitability

EPS (TTM): -0.44560
Net Income (TTM): $-34.9M
Gross Margin: $80.7M
Return on Equity: -23.25%
Return on Assets: -9.83%

Niu Technologies Earnings Forecast

Key Niu Technologies Financial Ratios

  • The Gross Profit Margin over the past 8 years for NIU is 21.52%.
  • The Selling, General & Administrative Expenses for NIU have been equal to 22.66% of Gross Profit Margin.
  • The Research & Development expenses have been 5.69% of Revenue.
  • The Interest Expense is -0.52% of Operating Income.
  • The Net Earning history of NIU is -10.25% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

Niu Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Automobiles
Sector: Consumer Discretionary
Current Symbol: NIU
CUSIP: 65481N
Website: niu.com

Debt

Debt-to-Equity Ratio: 0.46
Current Ratio: 1.33
Quick Ratio: 0.68

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 4122.21

NIU Technical Analysis vs Fundamental Analysis

Sell
29
Niu Technologies (NIU) is a Sell

Is Niu Technologies a Buy or a Sell?

  • Niu Technologies stock is rated a Sell
    The current Niu Technologies [NIU] share price is $1.76. The Score for NIU is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.